Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

Presentation TCT 2025

Case in the Box– Venous– IVUS and Scaffold for DVT

Presenter: Erin Murphy

October 28, 2025

Presentation TCT 2025

Use of PAT and Other Perfusion Techniques in PAD/CLTI

Presenter: Teresa L. Carman

October 28, 2025

Presentation TCT 2025

Insights into PAD Pathogenesis from LIFE-BTK Substudies

Presenter: Sahil A. Parikh

October 28, 2025

Presentation TCT 2025

Multi-societal “Get a Pulse on PAD” Campaign: What We’ve Learned and the Impact So Far

Presenter: Laurie Mobley

October 27, 2025

Presentation TCT 2025

Emerging Therapies: The Role of GLP-1 Agonists and SGLT2 Inhibitors in PAD/CLTI Management. Impact on the Guidelines

Presenter: Marc P. Bonaca

October 27, 2025

Presentation TCT 2025

CFA: Is it Still Surgery First?

Presenter: Matthew T. Menard

October 26, 2025

Presentation TCT 2025

Long Segment SFA Disease – Surgery vs. PTAB

Presenter: Ehrin J. Armstrong

October 26, 2025

Presentation TCT 2025

TCT 1932: Targeted Drugs, PADN, and Transcatheter Closure for Atrial Septal Defect-associated Pulmonary Hypertension: Case Series

Presenter: Nanchao Hong

October 26, 2025

Presentation TCT 2025

Prepping the SFA with IVL vs. Atherectomy – 2025 State of the Art

Presenter: Brian G. DeRubertis

October 26, 2025

Presentation TCT 2025

Does the SIRONA Trial Answer Our Questions about Sirolimus in the SFA?

Presenter: Dierk Scheinert

October 26, 2025

Presentation TCT 2025

Landscape of Drug Eluting Technology for SFA

Presenter: Aloke Finn

October 26, 2025

Presentation TCT 2025

TCT 1760: Left Main and LAD Severely Calcified Last Remaining Vessel Protected PCI in Low EF and Severe PAD: Many Tasks All at a Time

Presenter: Anita Paggi

October 25, 2025

Presentation TCT 2025

TCT 1397: Peripheral Arterial Disease (PAD) and TAVR: Roadblock Management

Presenter: Kevin Tijerina Flores

October 25, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

Podcast Heart Sounds

Top Cardiology News for June 2025

June 25, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

Presentation Fellows 2025

Workup and Treatment of Lower-Extremity PAD: What All Interventionalists Need to Know

Presenter: Sahil A. Parikh

May 18, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

Advertisement

Case in the Box– Venous– IVUS and Scaffold for DVT

Use of PAT and Other Perfusion Techniques in PAD/CLTI

Insights into PAD Pathogenesis from LIFE-BTK Substudies

Multi-societal “Get a Pulse on PAD” Campaign: What We’ve Learned and the Impact So Far

Emerging Therapies: The Role of GLP-1 Agonists and SGLT2 Inhibitors in PAD/CLTI Management. Impact on the Guidelines

CFA: Is it Still Surgery First?

Long Segment SFA Disease – Surgery vs. PTAB

TCT 1932: Targeted Drugs, PADN, and Transcatheter Closure for Atrial Septal Defect-associated Pulmonary Hypertension: Case Series

Prepping the SFA with IVL vs. Atherectomy – 2025 State of the Art

Does the SIRONA Trial Answer Our Questions about Sirolimus in the SFA?

Landscape of Drug Eluting Technology for SFA

TCT 1760: Left Main and LAD Severely Calcified Last Remaining Vessel Protected PCI in Low EF and Severe PAD: Many Tasks All at a Time

TCT 1397: Peripheral Arterial Disease (PAD) and TAVR: Roadblock Management

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Top Cardiology News for June 2025

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

Workup and Treatment of Lower-Extremity PAD: What All Interventionalists Need to Know

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content